Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells

We examined the effects of the histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA) combined with the vascular endothelial growth factor receptor-1/2 inhibitor (3Z)-5-hydroxy-3-(1H-pyrrol-2-ylmethylidene)-2,3-dihydro-1H-indol-2-one on MDA-MB-231 breast cancer cells (triple-ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Librizzi, Mariangela, Spencer, John, Luparello, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000633/
https://www.ncbi.nlm.nih.gov/pubmed/27483253
http://dx.doi.org/10.3390/ijms17081235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000633/
https://www.ncbi.nlm.nih.gov/pubmed/27483253
http://dx.doi.org/10.3390/ijms17081235

Ejemplares similares